The estimated Net Worth of Scott G Ginn is at least $11.4 Milione dollars as of 28 May 2021. Mr. Ginn owns over 975 units of Amedisys stock worth over $2,909,724 and over the last 13 years he sold AMED stock worth over $5,726,619. In addition, he makes $2,721,100 as Chief Financial Officer at Amedisys.
Scott has made over 29 trades of the Amedisys stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 975 units of AMED stock worth $26,666 on 28 May 2021.
The largest trade he's ever made was selling 23,828 units of Amedisys stock on 8 May 2017 worth over $1,396,797. On average, Scott trades about 2,132 units every 52 days since 2012. As of 28 May 2021 he still owns at least 30,084 units of Amedisys stock.
You can see the complete history of Mr. Ginn stock trades at the bottom of the page.
Scott G. Ginn serves as Chief Financial Officer of the Company since October 2017. He previously served as Chief Accounting Officer from February 2017 to October 2017, Senior Vice President of Finance and Accounting from October 2015 to February 2017 and Senior Vice President of Accounting and Controller from April 2007 to October 2015. Prior to joining the Company, he was a Director at Postlethwaite & Netterville, a professional accounting corporation. Mr. Ginn is a Certified Public Accountant.
As the Chief Financial Officer of Amedisys, the total compensation of Scott Ginn at Amedisys is $2,721,100. There are 2 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of $12,835,500.
Scott Ginn is 51, he's been the Chief Financial Officer of Amedisys since 2017. There are 18 older and 2 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
Scott's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... e David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
Amedisys executives and other stock owners filed with the SEC include: